Showing results (1601-1610 of 10,441) with videos related to
Sort By:
Pageof 1,045
AIDS (London, England)|November 13, 2019
Global status of Toxoplasma gondii infection and associated risk factors in people living with HIVHanie Safarpour, Muge Cevik, Mehdi Zarean, et al.AIDS (London, England)|December 6, 2019
Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levelsJohn Stover, Robert Glaubius, Lynne Mofenson, et al.AIDS (London, England)|March 14, 2020
Impact of the 12 January 2010 earthquake on HIV case reporting in HaitiChris Delcher, Jungjun Bae, Shannan N Rich, et al.AIDS (London, England)|March 14, 2020
Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIVXinzhu Wang, Marta Boffito, Laura Dickinson, et al.AIDS (London, England)|March 25, 2020
Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxisEric C Tang, Eric Vittinghoff, Susan S Philip, et al.AIDS (London, England)|December 12, 2018
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?Mattia Trunfio, Carmela Pinnetti, Emanuele Focà, et al.AIDS (London, England)|January 17, 2019
Long-term effects of unintended pregnancy on antiretroviral therapy outcomes among South African women living with HIVKirsty Brittain, Tamsin K Phillips, Allison Zerbe, et al.AIDS (London, England)|November 26, 2019
Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infectionRaphael Veil, Isabelle Poizot-Martin, Jacques Reynes, et al.AIDS (London, England)|November 26, 2019
Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapyTalia Sainz, Sergio Serrano-Villar, Surinder Mann, et al.AIDS (London, England)|November 26, 2019
Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and backAna Milinkovic, Florian Berger, Alejandro Arenas-Pinto, et al.Pageof 1,045